The presence of ibrutinib in CLL cell cultures is reported to induce apoptosis [156] and to also inhibit the prosurvival effects of BCR cross-linking and coculture with supporting nurse-like cells [3]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.